JP2025513240A5 - - Google Patents

Info

Publication number
JP2025513240A5
JP2025513240A5 JP2024560674A JP2024560674A JP2025513240A5 JP 2025513240 A5 JP2025513240 A5 JP 2025513240A5 JP 2024560674 A JP2024560674 A JP 2024560674A JP 2024560674 A JP2024560674 A JP 2024560674A JP 2025513240 A5 JP2025513240 A5 JP 2025513240A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
subject
composition according
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024560674A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/018952 external-priority patent/WO2023205153A1/en
Publication of JP2025513240A publication Critical patent/JP2025513240A/ja
Publication of JP2025513240A5 publication Critical patent/JP2025513240A5/ja
Pending legal-status Critical Current

Links

JP2024560674A 2022-04-19 2023-04-18 慢性肺同種移植片機能不全を治療するためのベルモスジル Pending JP2025513240A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263332628P 2022-04-19 2022-04-19
US63/332,628 2022-04-19
US202263389444P 2022-07-15 2022-07-15
US63/389,444 2022-07-15
PCT/US2023/018952 WO2023205153A1 (en) 2022-04-19 2023-04-18 Belumosudil for treating chronic lung allograft dysfunction

Publications (2)

Publication Number Publication Date
JP2025513240A JP2025513240A (ja) 2025-04-24
JP2025513240A5 true JP2025513240A5 (cg-RX-API-DMAC7.html) 2026-04-27

Family

ID=86330932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560674A Pending JP2025513240A (ja) 2022-04-19 2023-04-18 慢性肺同種移植片機能不全を治療するためのベルモスジル

Country Status (11)

Country Link
US (1) US20250255867A1 (cg-RX-API-DMAC7.html)
EP (1) EP4511036A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513240A (cg-RX-API-DMAC7.html)
KR (1) KR20250003657A (cg-RX-API-DMAC7.html)
CN (1) CN119031914A (cg-RX-API-DMAC7.html)
AU (1) AU2023256541A1 (cg-RX-API-DMAC7.html)
CA (1) CA3249201A1 (cg-RX-API-DMAC7.html)
IL (1) IL316410A (cg-RX-API-DMAC7.html)
MX (1) MX2024012802A (cg-RX-API-DMAC7.html)
TW (1) TW202404602A (cg-RX-API-DMAC7.html)
WO (1) WO2023205153A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102993352B1 (ko) 2019-12-20 2026-07-22 프린시피아 바이오파마, 인코퍼레이티드 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-에네니트릴의 고체 형태
AU2024292378A1 (en) * 2023-07-17 2026-03-05 Kadmon Corporation, Llc Combination therapy comprising btk inhibitor and belumosudil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
RS63503B1 (sr) 2012-10-05 2022-09-30 Kadmon Corporation Llc Inhibitori rho kinaze
US11311541B2 (en) * 2014-04-09 2022-04-26 Kadmon Corporation, Llc Treatment of GVHD

Similar Documents

Publication Publication Date Title
ES2144980T3 (es) Composiciones para tratar la rinitis alergica y otros trastornos descarboetoxiloratadina.
JP6810152B2 (ja) サクビトリルおよびバルサルタンの組合せの新規使用
CN110801452B (zh) 一种含有阿利沙坦酯水解产物或其水解产物盐的药物组合物及其用途
CA3253383A1 (en) Stabilizer systems for medical procedures that maintain sterility of an articulating arm above a sterile barrier
JP2015526458A5 (cg-RX-API-DMAC7.html)
US20220202826A1 (en) Methods for treating gi tract disorders
JP6052175B2 (ja) 左室拡張機能改善剤
JP2023520469A5 (cg-RX-API-DMAC7.html)
US20230277630A1 (en) Methods and compositions for treating amyotrophic lateral sclerosis
JP2019526644A (ja) Fxrアゴニストの組合せ
US20050239719A1 (en) Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension
JP2025522788A (ja) アミノステロール化合物、アミノステロール-シクロデキストリン製剤及びその使用方法
Goldschmidt et al. Compound cardiac toxicity of oral erythromycin and verapamil
RU2322238C2 (ru) Лечение ревматоидного артрита
TW202525278A (zh) 治療慢性腎病及高血壓之方法
RU2024129466A (ru) Белумосудил для лечения хронической дисфункции аллотрансплантата легкого
JP2016050181A (ja) 血管炎治療剤
JP2021020917A (ja) サクビトリルおよびバルサルタンの組合せの新規使用
US20140349982A1 (en) Methods of treating ulcerative colitis
US12138272B2 (en) Methods and compositions for treating amyotrophic lateral sclerosis
WO1997044031A1 (en) Agent for treating allergic dermatitis
US20240100069A1 (en) Methods and Compositions for Treating Amyotrophic Lateral Sclerosis
CN118319906A (zh) 一种含有司巴森坦的药物组合物及其应用
WO2025018279A1 (ja) ヒト移植片対宿主病の治療薬およびその組合せ物
JP2013522187A (ja) アミオダロン休薬直後に投与する薬剤製造のドロネダロンまたはその医薬として許容され得る塩の使用